Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study (Q36999978)
Jump to navigation
Jump to search
scientific article published on 27 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study |
scientific article published on 27 March 2013 |
Statements
1 reference
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study (English)
1 reference
T M Beer
1 reference
C S Higano
1 reference
S F Slovin
1 reference
O Hamid
1 reference
S Tejwani
1 reference
A Harzstark
1 reference
J J Alumkal
1 reference
H I Scher
1 reference
K Chin
1 reference
P Gagnier
1 reference
M B McHenry
1 reference
27 March 2013
1 reference
1 reference
1813-1821
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference